These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 23291674

  • 1. Clinical features and treatment outcomes of six patients with disseminated intravascular coagulation resulting from acute promyelocytic leukemia and treated with recombinant human soluble thrombomodulin at a single institution.
    Kawano N, Kuriyama T, Yoshida S, Yamashita K, Ochiai H, Nakazaki S, Tasaki A, Ueda A.
    Intern Med; 2013; 52(1):55-62. PubMed ID: 23291674
    [Abstract] [Full Text] [Related]

  • 2. Pathogenesis of disseminated intravascular coagulation in patients with acute promyelocytic leukemia, and its treatment using recombinant human soluble thrombomodulin.
    Ikezoe T.
    Int J Hematol; 2014 Jul; 100(1):27-37. PubMed ID: 24217998
    [Abstract] [Full Text] [Related]

  • 3. Clinical features and outcomes of 35 disseminated intravascular coagulation cases treated with recombinant human soluble thrombomodulin at a single institution.
    Kawano N, Yoshida S, Ono N, Himeji D, Nagahiro Y, Sayaka Kawano, Yamashita K, Ikeda N, Uezono S, Ochiai H, Kawano F, Kikuchi I, Ishikawa F, Shimoda K, Ueda A, Akashi K.
    J Clin Exp Hematop; 2011 Jul; 51(2):101-7. PubMed ID: 22104308
    [Abstract] [Full Text] [Related]

  • 4. Effects of recombinant human soluble thrombomodulin treatment for disseminated intravascular coagulation at a single institution--an analysis of 62 cases caused by infectious diseases and 30 cases caused by hematological diseases.
    Kawano N, Tasaki A, Kuriyama T, Tahara Y, Yoshida S, Ono N, Himeji D, Yamashita K, Shibata Y, Goto T, Inoue T, Yokota-Ikeda N, Uezono S, Yuge A, Nishiguchi T, Kinjo T, Ogura Y, Beppu K, Ueda Y, Kinoshita M, Moritake H, Shimoda K, Ochiai H, Ueda A.
    Intern Med; 2014 Jul; 53(3):205-13. PubMed ID: 24492688
    [Abstract] [Full Text] [Related]

  • 5. Successful treatment of disseminated intravascular coagulation by recombinant human soluble thrombomodulin in patients with acute myeloid leukemia.
    Ookura M, Hosono N, Tasaki T, Oiwa K, Fujita K, Ito K, Lee S, Matsuda Y, Morita M, Tai K, Negoro E, Kishi S, Iwasaki H, Ueda T, Yamauchi T.
    Medicine (Baltimore); 2018 Nov; 97(44):e12981. PubMed ID: 30383650
    [Abstract] [Full Text] [Related]

  • 6. Recombinant human soluble thrombomodulin safely and effectively rescues acute promyelocytic leukemia patients from disseminated intravascular coagulation.
    Ikezoe T, Takeuchi A, Isaka M, Arakawa Y, Iwabu N, Kin T, Anabuki K, Sakai M, Taniguchi A, Togitani K, Yokoyama A.
    Leuk Res; 2012 Nov; 36(11):1398-402. PubMed ID: 22917769
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Thrombomodulin in the management of acute cholangitis-induced disseminated intravascular coagulation.
    Suetani K, Okuse C, Nakahara K, Michikawa Y, Noguchi Y, Suzuki M, Morita R, Sato N, Kato M, Itoh F.
    World J Gastroenterol; 2015 Jan 14; 21(2):533-40. PubMed ID: 25593469
    [Abstract] [Full Text] [Related]

  • 10. Thrombomodulin alfa treatment in patients with acute promyelocytic leukemia and disseminated intravascular coagulation: a retrospective analysis of an open-label, multicenter, post-marketing surveillance study cohort.
    Matsushita T, Watanabe J, Honda G, Mimuro J, Takahashi H, Tsuji H, Eguchi Y, Kitajima I, Sakata Y.
    Thromb Res; 2014 May 14; 133(5):772-81. PubMed ID: 24636871
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Multicenter clinical experience with recombinant soluble thrombomodulin for disseminated intravascular coagulation associated with severe acute cholecystitis.
    Ogura T, Eguchi T, Amano M, Sano T, Nishioka N, Miyano A, Tsujimae M, Tanimura H, Yamada T, Terashima Y, Okada A, Higuchi K.
    Thromb Res; 2019 Apr 14; 176():74-78. PubMed ID: 30780007
    [Abstract] [Full Text] [Related]

  • 13. In vitro studies on the role of recombinant human soluble thrombomodulin in the context of retinoic acid mediated APL differentiation syndrome.
    Kojima S, Nishioka C, Chi S, Yokoyama A, Ikezoe T.
    Leuk Res; 2017 Dec 14; 63():1-9. PubMed ID: 29055789
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Clinical Impact of Recombinant Soluble Thrombomodulin for Disseminated Intravascular Coagulation Associated with Severe Acute Cholangitis.
    Okuda A, Ogura T, Imanishi M, Miyano A, Nishioka N, Higuchi K.
    Gut Liver; 2018 Jul 15; 12(4):471-477. PubMed ID: 29699063
    [Abstract] [Full Text] [Related]

  • 16. [The efficacy of early use of recombinant soluble thrombomodulin for disseminated intravascular coagulation complicated with hematologic malignancies].
    Usami M, Kuroda H, Yoshida M, Sakamoto H, Shimoyama S, Kanari Y, Yamada M, Abe T, Fujii S, Maeda M.
    Rinsho Ketsueki; 2015 Jun 15; 56(6):673-80. PubMed ID: 26256878
    [Abstract] [Full Text] [Related]

  • 17. [Treatment with recombinant thrombomodulin on disseminated intravascular coagulation caused by urinary tract infections; a retrospective comparative study with control cases].
    Machioka K, Shigehara K, Kadomoto S, Iwamoto H, Miyagi T, Nakashima T, Namiki M.
    Hinyokika Kiyo; 2015 Jan 15; 61(1):1-6. PubMed ID: 25656012
    [Abstract] [Full Text] [Related]

  • 18. [Analysis of empirical treatment for newly diagnosed acute promyelocytic leukemia combined with disseminated intravascular coagulation].
    Yang H, Zhu CY, Wang QS, Niu JH, Zhang Q, Zhu HY, Yao ZL, Xu YY, Jing Y, Yu L.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr 15; 22(2):315-22. PubMed ID: 24762998
    [Abstract] [Full Text] [Related]

  • 19. Effect of Recombinant Human Soluble Thrombomodulin on Coagulation-Related Variables in Patients With Sepsis-Induced Disseminated Intravascular Coagulation: A Retrospective Observational Study.
    Mitaka C, Kawagoe I, Satoh D, Hayashida M.
    Clin Appl Thromb Hemost; 2021 Apr 15; 27():10760296211050356. PubMed ID: 34859680
    [Abstract] [Full Text] [Related]

  • 20. Comparison of recombinant human thrombomodulin and gabexate mesylate for treatment of disseminated intravascular coagulation (DIC) with sepsis following emergent gastrointestinal surgery: a retrospective study.
    Akahoshi T, Sugimori H, Kaku N, Tokuda K, Nagata T, Noda E, Morita M, Hashizume M, Maehara Y.
    Eur J Trauma Emerg Surg; 2015 Oct 15; 41(5):531-8. PubMed ID: 26038004
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.